SLO-RP Preserve is a global Phase 3 clinical trial evaluating whether NPI-001 tablets can slow vision loss caused by retinitis pigmentosa (RP) in patients with Usher syndrome.The trial is currently enrolling participants at sites in the United States and Australia. Use the clinical trial site locator below to find the site closest to you or view our list of participating study sites. If you do not see a study site near you or within your country, please check back periodically, as additional study locations may be added in the future. Travel assistance may be available for eligible participants. If you are interested in participating, please contact a study site to learn more about available travel support.For more information, please visit the trial page on www.ClinicalTrials.gov.
Prefer not to use the map? Browse all study sites by location.
Associated Retina Consultants1750 E Glendale AvePhoenix, Arizona 85020Site Contact:Mallory MintertPhone number: 480-999-5458Email: mallory.mintert@doctrials.com
Retina Foundation of the Southwest9600 North Central ExpresswaySuite 200Dallas, Texas 75231Site Contact:Jadan CrowPhone number: 214-363-3911, ext. 162Email: jcrow@retinafoundation.org
Lions Eye Institute2 Verdun StNedlands, WA 6009Site Contact:Quang (Steven) PhamPhone number: 61893810871Email: quang.pham@lei.org.au
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
You can find more information in our .